United Laboratories International (ULIHF) Expected to Announce Earnings on Tuesday

United Laboratories International (OTCMKTS:ULIHFGet Free Report) is expected to be announcing its results before the market opens on Tuesday, March 24th. Analysts expect the company to announce earnings of $0.0315 per share and revenue of $783.4010 million for the quarter.

United Laboratories International Stock Performance

United Laboratories International stock opened at $1.70 on Friday. The business has a fifty day moving average of $1.79 and a two-hundred day moving average of $1.90. United Laboratories International has a twelve month low of $1.60 and a twelve month high of $1.70.

About United Laboratories International

(Get Free Report)

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.

Featured Articles

Receive News & Ratings for United Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.